CHEST澳大利亚试验:行为干预提高肺癌高危吸烟者呼吸症状就诊率
该随机对照试验纳入551名55岁及以上、吸烟≥20包年的长期吸烟者,评估CHEST行为干预(咨询+自助手册+自我监测提醒)对呼吸症状就诊率的影响。干预组呼吸相关就诊率相对增加40%(相对率1.40,95%CI 1.08-1.82,p=0.0123),未见心理伤害差异,增量成本效果比为每增加一次呼吸就诊1289澳元。
要点
- CHEST行为干预可显著提高肺癌高危吸烟者的呼吸症状就诊率。
- 干预组呼吸就诊率相对增加40%,未见心理伤害差异。
- 该干预或可作为基层呼吸健康管理的一部分。
核心结论
- 行为干预可显著增加肺癌高危患者的呼吸症状就诊率。
研究设计与样本
- 平行、个体随机对照试验,纳入551名55岁及以上、吸烟≥20包年的长期吸烟者,1:1电话随机分组,按MRC呼吸困难评分和全科诊所分层。
主要发现
- 干预组呼吸就诊调整率0.57(95%CI 0.47-0.70),对照组0.41(95%CI 0.32-0.52),相对率1.40(95%CI 1.08-1.82),p=0.0123。
- 首次呼吸就诊时间、总就诊率及心理伤害指标组间无显著差异。
- 增量成本效果比为每增加一次呼吸就诊1289澳元。
临床怎么用
- 在基层对肺癌高危吸烟者实施行为干预(咨询+自助手册+自我监测提醒)可促进呼吸症状就诊。
局限性
- 参与者无法设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: International research has focused on screening and mass media campaigns to promote earlier patient presentation and detect lung cancer earlier. This trial tested the effect of a behavioural intervention in people at increased risk of lung cancer on help-seeking for respiratory symptoms. METHODS: Parallel, individually randomised controlled trial. Eligible participants were long-term smokers with at least 20 pack-years, aged 55 and above. The CHEST intervention entailed a consultation to discuss and implement a self-help manual, followed by self-monitoring reminders to encourage help-seeking for respiratory symptoms. The control group received a brief discussion about lung health. Both groups had baseline spirometry. Telephone randomisation was conducted, 1:1, stratified Medical Research Council (MRC) dyspnoea score and general practice. Participants could not be blinded; data extraction and statistical analyses were performed blinded to group assignment. The primary outcome was respiratory consultation rates. RESULTS: We randomised 551 participants (274 intervention, 277 control) from whom the primary outcome was determined for 542 (269 intervention, 273 control). There was a 40% relative increase in respiratory consultations in the intervention group: (adjusted rates (95% CI) intervention 0.57 (0.47 to 0.70), control 0.41 (0.32 to 0.52), relative rate 1.40 (1.08 to 1.82); p=0.0123). There were no significant differences in time to first respiratory consultation, total consultation rates or measures of psychological harm. The incremental cost-effectiveness ratio was $A1289 per additional respiratory consultation. CONCLUSIONS: A behavioural intervention can significantly increase consulting for respiratory symptoms in patients at increased risk of lung cancer. This intervention could have an important role in primary care as part of a broader approach to improve respiratory health in patients at higher risk. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trial Registry (1261300039 3752). This was registered pre-results.
引用
- Emery JD, Murray SR, Walter FM, et al. The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax. 2019. PMID: 30630891. doi:10.1136/thoraxjnl-2018-212506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。